(1) A licensing board shall not revoke, fail to renew, suspend, or take any action against a licensed health care provider based solely on the health care provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device.
(2) The Cabinet for Health and Family Services shall not take action against a health care provider’s Medicare or Medicaid certification based solely on the health care provider’s recommendation that a patient have access to an investigational drug, biological product, or device.

Terms Used In Kentucky Statutes 217.5407

  • Action: includes all proceedings in any court of this state. See Kentucky Statutes 446.010
  • Board: means the Pesticide Advisory Board. See Kentucky Statutes 217.544
  • Device: means any instrument or contrivance other than a firearm which is intended for trapping, destroying, repelling, or mitigating any pest or any other form of plant or animal life other than man and other bacteria, virus, or other microorganisms on or in living man or other living animals. See Kentucky Statutes 217.544
  • Treatment: when used in a criminal justice context, means targeted interventions
    that focus on criminal risk factors in order to reduce the likelihood of criminal behavior. See Kentucky Statutes 446.010

Effective: June 29, 2017
History: Created 2017 Ky. Acts ch. 65, sec. 7, effective June 29, 2017.
Formerly codified as KRS § 217.5413.

  Previous section
Next section  
 Chapter 217 Contents